Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Journal of Translational Medicine
|
May 15, 2025
Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes
Narainrit Karuna, Claire Tonry, Mark Ledwidge, et al.
International Journal of Heart Failure
|
October 20, 2022
Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?
Brian Kerr, Rebabonye B Pharithi, Matthew Barrett, et al.
European Journal of Heart Failure
|
February 19, 2005
Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs
Mark Ledwidge, Enda Ryan, Christina O'Loughlin, et al.
Clinical Chemistry and Laboratory Medicine
|
February 1, 2011
B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study
Carmel M Conlon, Ian Dawkins, Christina O'Loughlin, et al.
International Journal of Cardiology. Heart & Vasculature
|
January 3, 2022
Reassuring cardiac and non-cardiac outcomes for heart failure patients managed in a disease management programme during the COVID-19 pandemic
Joseph McCambridge, Katherine McDonald, Líbhan Collins, et al.
Acta Haematologica
|
January 5, 2018
Novel Iron-Whey Protein Microspheres Protect Gut Epithelial Cells from Iron-Related Oxidative Stress and Damage and Improve Iron Absorption in Fasting Adults
Jun Wang, Gabor Radics, Michael Whelehan, et al.
International Journal of Clinical Pharmacy
|
December 26, 2023
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation : Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION)
Mark Ledwidge, Fiona Ryan, Anna Seoighe, et al.
Cardiovascular Diabetology
|
May 14, 2025
Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease
Narainrit Karuna, Lauren Kerrigan, Kevin Edgar, et al.
Biomedicines
|
August 29, 2024
Proteomic Characterisation of Heart Failure Reveals a Unique Molecular Phenotype for Hypertrophic Cardiomyopathy
Claire Tonry, Katie Linden, Patrick Collier, et al.
The Cochrane Database of Systematic Reviews
|
October 16, 2019
Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure
Claire Sweeney, Fiona Ryan, Mark Ledwidge, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Journal of Translational Medicine
|
May 15, 2025
Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes
Narainrit Karuna, Claire Tonry, Mark Ledwidge, et al.
International Journal of Heart Failure
|
October 20, 2022
Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?
Brian Kerr, Rebabonye B Pharithi, Matthew Barrett, et al.
European Journal of Heart Failure
|
February 19, 2005
Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs
Mark Ledwidge, Enda Ryan, Christina O'Loughlin, et al.
Clinical Chemistry and Laboratory Medicine
|
February 1, 2011
B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study
Carmel M Conlon, Ian Dawkins, Christina O'Loughlin, et al.
International Journal of Cardiology. Heart & Vasculature
|
January 3, 2022
Reassuring cardiac and non-cardiac outcomes for heart failure patients managed in a disease management programme during the COVID-19 pandemic
Joseph McCambridge, Katherine McDonald, Líbhan Collins, et al.
Acta Haematologica
|
January 5, 2018
Novel Iron-Whey Protein Microspheres Protect Gut Epithelial Cells from Iron-Related Oxidative Stress and Damage and Improve Iron Absorption in Fasting Adults
Jun Wang, Gabor Radics, Michael Whelehan, et al.
International Journal of Clinical Pharmacy
|
December 26, 2023
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation : Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION)
Mark Ledwidge, Fiona Ryan, Anna Seoighe, et al.
Cardiovascular Diabetology
|
May 14, 2025
Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease
Narainrit Karuna, Lauren Kerrigan, Kevin Edgar, et al.
Biomedicines
|
August 29, 2024
Proteomic Characterisation of Heart Failure Reveals a Unique Molecular Phenotype for Hypertrophic Cardiomyopathy
Claire Tonry, Katie Linden, Patrick Collier, et al.
The Cochrane Database of Systematic Reviews
|
October 16, 2019
Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure
Claire Sweeney, Fiona Ryan, Mark Ledwidge, et al.
Page
of 11